From January 1, 2023 to February 2, 2023, the company has repurchased 22,972 shares, representing 0.007245% for CNY 1.67 million. With this, the company has completed the repurchase of 1,459,586 shares, representing 0.46% for CNY 99.69 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.18 CNY | +5.45% | +10.52% | +1.63% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.63% | 1.71B | |
+11.29% | 226B | |
+8.97% | 188B | |
+13.29% | 137B | |
+26.13% | 108B | |
+0.34% | 63.19B | |
+11.53% | 52.26B | |
+5.62% | 51B | |
+6.31% | 43.89B | |
+4.80% | 38.07B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.